D-Wave Quantum Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by D-Wave Quantum Inc. on May 21, 2026. The filing discloses a significant corporate event under Item 8.01 (Other Events) regarding a proposed government funding agreement.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for a specific reporting period. The primary financial figure disclosed is a proposed funding amount of $100 million.
Material Changes and Events
- Letter of Intent (LOI): D-Wave signed an LOI for $100 million in proposed funding under the U.S. CHIPS and Science Act, administered by the U.S. Department of Commerce.
- Equity Issuance: In connection with the funding, D-Wave would issue $100 million worth of its common stock to the Department of Commerce.
- Strategic Use of Funds: The funding is intended to accelerate the development and scaling of annealing and gate-model quantum systems.
- Facility Expansion: Resources will support R&D facilities in Boca Raton, Florida; New Haven, Connecticut; and Burnaby, BC, Canada.
Guidance, Outlook, and Risks
Management views the LOI as a transformative moment and a significant endorsement of D-Wave's technology. However, the transaction is subject to several contingencies:
- Definitive Agreement: The funding and share issuance are contingent upon the execution of definitive award documents.
- Forward-Looking Risks: Risks include the failure to execute documents within the expected timeframe, suspension or termination of negotiations by the Department, inability to satisfy disbursement conditions (including project milestones), and the availability of appropriated funds.
- Dilution: The issuance of shares to the Department poses a risk of dilution to existing stockholders.
Investor Verification Checklist
- Verify the execution status of the definitive award documents between D-Wave and the Department of Commerce.
- Confirm the specific terms and conditions regarding the issuance of $100 million in common stock.
- Monitor for any updates on the availability of appropriated funds under the CHIPS and Science Act.
- Review the specific project milestones required for the disbursement of the funding.